John Scott

4.4k total citations · 1 hit paper
65 papers, 3.1k citations indexed

About

John Scott is a scholar working on Statistics and Probability, Molecular Biology and Economics and Econometrics. According to data from OpenAlex, John Scott has authored 65 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Statistics and Probability, 11 papers in Molecular Biology and 10 papers in Economics and Econometrics. Recurrent topics in John Scott's work include Statistical Methods in Clinical Trials (18 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Bipolar Disorder and Treatment (8 papers). John Scott is often cited by papers focused on Statistical Methods in Clinical Trials (18 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Bipolar Disorder and Treatment (8 papers). John Scott collaborates with scholars based in United States, United Kingdom and Canada. John Scott's co-authors include David J. Kupfer, Ellen Frank, Andrea Fagiolini, Kenneth A. Perkins, Patricia R. Houck, Holly A. Swartz, Scott R. Turkin, Timothy H. Monk, Michael E. Thase and Alan G. Mallinger and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

John Scott

64 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Two-Year Outcomes for Interpersonal and Social Rhythm Therapy in Individuals With Bipolar I Disorder

2005 524 citations Ellen Frank, David J. Kupfer et al. profile →

Peers

Countries citing papers authored by John Scott

Since Specialization

Citations

This map shows the geographic impact of John Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Scott more than expected).

Fields of papers citing papers by John Scott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Scott. The network helps show where John Scott may publish in the future.

Co-authorship network of co-authors of John Scott

This figure shows the co-authorship network connecting the top 25 collaborators of John Scott. A scholar is included among the top collaborators of John Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Scott. John Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical and Statistical Perspectives on the ICH E9(R1) Estimand Framework Implementation 2022 ·Statistics in Biopharmaceutical Research ·Alexei Ionan, (unknown), Devan V. Mehrotra, John Scott, Bohdana Ratitch, Sylva H. Collins, Shanti Gomatam, (unknown), Kaspar Rufibach, Frank Bretz	5
2	Summary of US Food and Drug Administration Chimeric Antigen Receptor (CAR) T-Cell Biologics License Application Approvals From a Statistical Perspective 2022 ·Journal of Clinical Oncology ·Xue Lin, Shiowjen Lee, (unknown), Bindu George, John Scott	18
3	Bayesian Methods in Human Drug and Biological Products Development in CDER and CBER 2022 ·Therapeutic Innovation & Regulatory Science ·Alexei Ionan, (unknown), James Travis, Anup Amatya, John Scott, James P. Smith, Somesh Chattopadhyay, (unknown), Mark D. Rothmann	10
4	Graphical Analyses in the Regulatory Evaluation of Gene Therapy Applications 2020 ·Therapeutic Innovation & Regulatory Science ·Xue Lin, Shiowjen Lee, John Scott, Min Lin	2
5	Addressing prior-data conflict with empirical meta-analytic-predictive priors in clinical studies with historical information 2016 ·Journal of Biopharmaceutical Statistics ·(unknown), (unknown), John Scott	7
6	A new algorithmic approach for the extraction of temporal associations from clinical narratives with an application to medical product safety surveillance reports 2016 ·Journal of Biomedical Informatics ·Wei Wang, Kory Kreimeyer, Emily Jane Woo, Robert Ball, Matthew Foster, Abhishek Pandey, John Scott, Taxiarchis Botsis	22
7	Management of a Patient With Tetralogy of Fallot, Congenital Diaphragmatic Hernia, and Complete Left Lung Agenesis 2016 ·A & A Case Reports ·(unknown), George M. Hoffman, John Scott	1
8	CBER’s Experience With Adaptive Design Clinical Trials 2015 ·Therapeutic Innovation & Regulatory Science ·Min Lin, Shiowjen Lee, Boguang Zhen, John Scott, (unknown), (unknown), Estelle Russek‐Cohen	31
9	Simulating adverse event spontaneous reporting systems as preferential attachment networks 2014 ·Applied Clinical Informatics ·Taxiarchis Botsis, Ron O. Ball, John Scott	8
10	Quantitative cw Overhauser effect dynamic nuclear polarization for the analysis of local water dynamics 2013 ·Progress in Nuclear Magnetic Resonance Spectroscopy ·John M. Franck, Ànna Pavlova, John Scott, Songi Han	110
11	Sample Size Estimation in Single-Arm Clinical Trials with Multiple Testing Under Frequentist and Bayesian Approaches 2012 ·Journal of Biopharmaceutical Statistics ·Boris G. Zaslavsky, John Scott	2
12	Variability in initial nicotine sensitivity due to sex, history of other drug use, and parental smoking 2008 ·Drug and Alcohol Dependence ·Kenneth A. Perkins, (unknown), Joshua L. Karelitz, (unknown), John Scott, Annette Wilson, Caryn Lerman	33
13	Sex differences in long-term smoking cessation rates due to nicotine patch 2008 ·Nicotine & Tobacco Research ·Kenneth A. Perkins, John Scott	264
14	Daytime symptoms in primary insomnia: A prospective analysis using ecological momentary assessment 2007 ·Sleep Medicine ·Daniel J. Buysse, Wesley K. Thompson, John Scott, Peter L. Franzen, Anne Germain, Martica H. Hall, Douglas E. Moul, Eric A. Nofzinger, David J. Kupfer	219
15	Hypothyroidism in patients with Bipolar I Disorder treated primarily with lithium 2006 ·Epidemiologia e Psichiatria Sociale ·Andrea Fagiolini, David J. Kupfer, John Scott, Holly A. Swartz, David M. Cook, Danielle M. Novick, Ellen Frank	41
16	An open-label trial of enhanced brief interpersonal psychotherapy in depressed mothers whose children are receiving psychiatric treatment 2006 ·Depression and Anxiety ·Holly A. Swartz, Allan Zuckoff, Ellen Frank, (unknown), M. Katherine Shear, Melissa Fleming, John Scott	32
17	Prevalence and Clinical Correlates of Medical Comorbidities in Patients With Bipolar I Disorder 2006 ·The Journal of Clinical Psychiatry ·Wesley K. Thompson, David J. Kupfer, Andrea Fagiolini, John Scott, Ellen Frank	58
18	A Chart Review of Cyproheptadine for Stimulant-Induced Weight Loss 2004 ·Journal of Child and Adolescent Psychopharmacology ·W. Burleson Daviss, John Scott	37
19	Suicide Attempts and Ideation in Patients With Bipolar I Disorder 2004 ·The Journal of Clinical Psychiatry ·Andrea Fagiolini, David J. Kupfer, Paola Rucci, John Scott, Danielle M. Novick, Ellen Frank	80
20	Polymerase Chain Reaction for the Diagnosis of HIV Infection in Adults 1996 ·Annals of Internal Medicine ·Douglas K Owens, Mark Holodniy, Alan M. Garber, John Scott, Seema S. Sonnad, Lincoln E. Moses, Bruce Kinosian, J. Sanford Schwartz	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact